Last $33.21 USD
Change Today +0.19 / 0.58%
Volume 535.3K
ANAC On Other Exchanges
Symbol
Exchange
NASDAQ GM
Berlin
As of 8:10 PM 12/18/14 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - anacor pharmaceuticals inc (ANAC)

NameBoard RelationshipsTitleAge
Paul L. Berns 47 RelationshipsChairman, Chief Executive Officer, President, Chairman of Compensation Committee, Chairman of Transaction Committee and Member of Audit Committee47
Lucy Shapiro Ph.D.45 RelationshipsCo-Founder, Co-Chair of Scientific Advisory Board, Director and Member of Nominating & Corporate Governance Committee73
Geoffrey M. Parker 21 RelationshipsChief Financial Officer, Principal Accounting Officer and Executive Vice President49
Sanjay Chanda Ph.D.No RelationshipsSenior Vice President of Drug Development49
Vincent P. Ippolito No RelationshipsChief Commercial Officer and Executive Vice President55

Board Members - anacor pharmaceuticals inc (ANAC)

NameBoard RelationshipsPrimary CompanyAge
Paul L. Berns 47 RelationshipsAnacor Pharmaceuticals, Inc.47
Lucy Shapiro Ph.D.45 RelationshipsAnacor Pharmaceuticals, Inc.73
William J. Rieflin 30 RelationshipsXenoport, Inc.54
Mark Leschly 144 RelationshipsRho Capital Partners, Inc.45
Martin Rosenberg Ph.D.40 RelationshipsVantagePoint Capital Partners68

Executive Committees* - anacor pharmaceuticals inc (ANAC)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeWilliam J. Rieflin 30 Relationships2 Executives
Compensation CommitteePaul L. Berns 47 Relationships3 Executives
Advisory BoardLucy Shapiro Ph.D. 45 Relationships8 Executives
View ANAC Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ANAC:US $33.21 USD +0.19

ANAC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ANAC.
View Industry Companies
 

Industry Analysis

ANAC

Industry Average

Valuation ANAC Industry Range
Price/Earnings 26.4x
Price/Sales 71.6x
Price/Book 22.3x
Price/Cash Flow 26.4x
TEV/Sales 63.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ANACOR PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.